Related Experiment Video

Updated: May 14, 2026

Sequential Salt Extractions for the Analysis of Bulk Chromatin Binding Properties of Chromatin Modifying Complexes
07:41

Sequential Salt Extractions for the Analysis of Bulk Chromatin Binding Properties of Chromatin Modifying Complexes

Published on: October 2, 2017

When are the BET factors the most sensitive to bromodomain inhibitors?

Saadi Khochbin1

  • 1INSERM, U823, Université Joseph Fourier - Grenoble 1, Institut Albert Bonniot Grenoble, France. khochbin@ujf-grenoble.fr

Transcription
|February 16, 2013
PubMed

Insights

BET bromodomain inhibitors impact mouse spermatogenesis. New studies using chemical inhibition and genetic alterations of Brdt offer insights into their functional effects on sperm development.

Area of Science:

  • Reproductive Biology
  • Molecular Biology
  • Genetics

Background:

  • BET bromodomains are epigenetic regulators implicated in gene transcription.
  • Spermatogenesis, the process of sperm production, is crucial for male fertility.
  • Inhibitors targeting BET bromodomains are being explored for therapeutic applications.

Purpose of the Study:

  • To evaluate the functional impact of BET bromodomain inhibitors on mouse spermatogenesis.
  • To understand the role of Brdt, a specific BET protein, in male germ cell development.

Main Methods:

  • Analysis of two recent studies on mouse spermatogenesis.
  • Comparison of outcomes following chemical inhibition of BET bromodomains.
  • Assessment of spermatogenesis in mice with genetic alterations of the Brdt gene.

Main Results:

  • Chemical inhibition of BET bromodomains affects spermatogenesis.
  • Genetic alterations of Brdt lead to observable impacts on sperm development.
  • These studies provide a comprehensive view of BET inhibitor effects.

Conclusions:

  • BET bromodomain inhibitors have a significant functional impact on spermatogenesis.
  • Targeting Brdt offers a potential avenue for modulating male reproductive processes.
  • Further research is warranted to fully elucidate the mechanisms involved.
Keywords:
Brd2Brd3Brd4BrdtacetylationcancerchromatinhistoneinfertilitypTEFbspermatogenesis

More Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...